Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients (ITTC Trial): A Single-Center, Prospective, Randomized Controlled Trial

NCT06543849 is registered in ClinicalTrials.gov with Tang Ziren as lead sponsor.

NCT NCT06543849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06543849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients (ITTC Trial): A Single-Center, Prospective, Randomized Controlled Trial
Lead sponsor
Tang Ziren
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2024
Completion date
December 31, 2025
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, targeted temperature management, thrombin function, treatment duration